Gu, C., Cheng, H., Yang, H., Bian, Y., Wang, Y., Zhang, Y., Pisano, M., Hu, G. and Yang, Y. (2021) “MK2 is a therapeutic target for high-risk multiple myeloma”, Haematologica. Pavia, Italy, 106(6), pp. 1774-1777. doi: 10.3324/haematol.2017.182121.